Cardiovascular morbidity between discharged and 12-month follow-up and medication for cardiovascular disease at 12-month follow-up
| Morbidity/medication | Randomised | Elective | ||
| Rehabilitation, n=795 | Control, n=811 | Rehabilitation, n=162 | Control, n=115 | |
| Myocardial infarction (MI) | 31 (3.9) | 39 (4.8) | 7 (4.3) | 8 (7.0) |
| Cerebrovascular accident (stroke) | 6 (0.8) | 11 (1.4) | 0 | 1 (0.9) |
| CABG | 44 (5.5) | 43 (5.3) | 7 (4.3) | 8 (7.0) |
| PTCA | 38 (4.8) | 44 (5.4) | 13 (8.0) | 9 (7.8) |
| Combined cardiac outcomes (MI, stroke, CABG, PTCA) | 104 (13.1) | 127 (15.7) | 24 (14.8) | 25 (21.7) |
| Other hospital admission for heart disease | 118 (14.8) | 112 (13.8) | 23 (14.2) | 16 (13.9) |
| Any admission for heart disease (MI, stroke, CABG, PTCA, other) | 222 (30) | 239 (29) | 47 (29) | 41 (36) |
| Angina in past 4 weeks | 242 (31) | 244 (31) | 51 (31) | 35 (31) |
| GP visits in past 4 weeks | 375 (48) | 383 (48) | 86 (53) | 60 (52) |
| Aspirin | 713 (91) | 719 (90) | 153 (94) | 101 (88) |
| β blocker | 432 (54) | 443 (55) | 106 (66) | 77 (68) |
| ACE inhibitor | 360 (45) | 356 (44) | 67 (42) | 47 (41) |
| Diuretic | 200 (25) | 221 (27) | 53 (33) | 39 (34) |
| Long acting nitrate/calcium channel blocker | 333 (42)* | 388 (48)* | 66 (41)† | 26 (23)† |
| GTN medication in last week | 191 (24) | 206 (25) | 34 (21) | 30 (26) |
| Statin | 468 (59) | 500 (62) | 126 (78)† | 70 (61)† |